<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Glatt, H.</title>
    <link>http://repub.eur.nl/res/aut/7010/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Characterization of rat iodothyronine sulfotransferases. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13161/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>Sulfation appears to be an important pathway for the reversible
      inactivation of thyroid hormone during fetal development. The rat is an
      often used animal model to study the regulation of fetal thyroid hormone
      status. The present study was done to determine which sulfotransferases
      (SULTs) are important for iodothyronine sulfation in the rat, using
      radioactive T4, T3, rT3, and 3,3'-T2 as substrates,
      3'-phosphoadenosine-5'-phosphosulfate (PAPS) as cofactor, and rat liver,
      kidney and brain cytosol, and recombinant rat SULT1A1, -1B1, -1C1, -1E1,
      -2A1, -2A2, and -2A3 as enzymes. Recombinant rat SULT1A1, -1E1, -2A1,
      -2A2, and -2A3 failed to catalyze iodothyronine sulfation. For all tissue
      SULTs and for rSULT1B1 and rSULT1C1, 3,3'-T2 was by far the preferred
      substrate. Apparent Km values for 3,3'-T2 amounted to 1.9 microM in male
      liver, 4.4 microM in female liver, 0.76 microM in male kidney, 0.23 microM
      in male brain, 7.7 microM for SULT1B1, and 0.62 microM for SULT1C1,
      whereas apparent Km values for PAPS showed less variation (2.0-6.9
      microM). Sulfation of 3,3'-T2 was inhibited dose dependently by other
      iodothyronines, with similar structure-activity relationships for most
      enzymes except for the SULT activity in rat brain. The apparent Km values
      of 3,3'-T2 in liver cytosol were between those determined for SULT1B1 and
      -1C1, supporting the importance of these enzymes for the sulfation of
      iodothyronines in rat liver, with a greater contribution of SULT1C1 in
      male than in female rat liver. The results further suggest that rSULT1C1
      also contributes to iodothyronine sulfation in rat kidney, whereas other,
      yet-unidentified forms appear more important for the sulfation of thyroid
      hormone in rat brain.</description>
    </item> <item>
      <title>Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters (Article)</title>
      <link>http://repub.eur.nl/res/pub/9872/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>Polyhalogenated aromatic hydrocarbons (PHAHs), such as polychlorinated
      dibenzo-p-dioxins and dibenzofurans, polybrominated diphenylethers, and
      bisphenol A derivatives are persistent environmental pollutants, which are
      capable of interfering with reproductive and endocrine function in birds,
      fish, reptiles, and mammals. PHAHs exert estrogenic effects that may be
      mediated in part by their hydroxylated metabolites (PHAH-OHs), the
      mechanisms of which remain to be identified. PHAH-OHs show low affinity
      for the ER. Alternatively, they may exert their estrogenic effects by
      inhibiting E2 metabolism. As sulfation of E2 by estrogen sulfotransferase
      (SULT1E1) is an important pathway for E2 inactivation, inhibition of
      SULT1E1 may lead to an increased bioavailability of estrogens in tissues
      expressing this enzyme. Therefore, we studied the possible inhibition of
      human SULT1E1 by hydroxylated PHAH metabolites and the sulfation of the
      different compounds by SULT1E1. We found marked inhibition of SULT1E1 by
      various PHAH-OHs, in particular by compounds with two adjacent halogen
      substituents around the hydroxyl group that were effective at
      (sub)nanomolar concentrations. Depending on the structure, the inhibition
      is primarily competitive or noncompetitive. Most PHAH-OHs are also
      sulfated by SULT1E1. We also investigated the inhibitory effects of the
      various PHAH-OHs on E2 sulfation by human liver cytosol and found that the
      effects were strongly correlated with their inhibitions of recombinant
      SULT1E1 (r = 0.922). Based on these results, we hypothesize that
      hydroxylated PHAHs exert their estrogenic effects at least in part by
      inhibiting SULT1E1-catalyzed E2 sulfation.</description>
    </item> <item>
      <title>Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs (Article)</title>
      <link>http://repub.eur.nl/res/pub/9366/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>Polychlorinated biphenyls (PCBs) are persistent environmental pollutants
          which exert a variety of toxic effects in animals, including disturbances
          of sexual development and reproductive function. The estrogenic effects of
          PCBs may be mediated in part by hydroxylated PCB metabolites (PCB-OHs),
          but the mechanisms by which they are brought about are not understood.
          PCBs as well as PCB-Hs show low affinities for both alpha and beta
          estrogen receptor isoforms. In the present study we demonstrate that
          various environmentally relevant PCB-OHs are extremely potent inhibitors
          of human estrogen sulfotransferase, strongly suggesting that they
          indirectly induce estrogenic activity by increasing estradiol
          bioavailability in target tissues.</description>
    </item> <item>
      <title>Characterization of human iodothyronine sulfotransferases (Article)</title>
      <link>http://repub.eur.nl/res/pub/9077/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>Sulfation is an important pathway of thyroid hormone metabolism that
          facilitates the degradation of the hormone by the type I iodothyronine
          deiodinase, but little is known about which human sulfotransferase
          isoenzymes are involved. We have investigated the sulfation of the
          prohormone T4, the active hormone T3, and the metabolites rT3 and
          3,3'-diiodothyronine (3,3'-T2) by human liver and kidney cytosol as well
          as by recombinant human SULT1A1 and SULT1A3, previously known as
          phenol-preferring and monoamine-preferring phenol sulfotransferase,
          respectively. In all cases, the substrate preference was 3,3'-T2 &gt;&gt; rT3 &gt;
          T3 &gt; T4. The apparent Km values of 3,3'-T2 and T3 [at 50 micromol/L
          3'-phosphoadenosine-5'-phosphosulfate (PAPS)] were 1.02 and 54.9
          micromol/L for liver cytosol, 0.64 and 27.8 micromol/L for kidney cytosol,
          0.14 and 29.1 micromol/L for SULT1A1, and 33 and 112 micromol/L for
          SULT1A3, respectively. The apparent Km of PAPS (at 0.1 micromol/L 3,3'-T2)
          was 6.0 micromol/L for liver cytosol, 9.0 micromol/L for kidney cytosol,
          0.65 micromol/L for SULT1A1, and 2.7 micromol/L for SULT1A3. The sulfation
          of 3,3'-T2 was inhibited by the other iodothyronines in a
          concentration-dependent manner. The inhibition profiles of the 3,3'-T2
          sulfotransferase activities of liver and kidney cytosol obtained by
          addition of 10 micromol/L of the various analogs were better correlated
          with the inhibition profile of SULT1A1 than with that of SULT1A3. These
          results indicate similar substrate specificities for iodothyronine
          sulfation by native human liver and kidney sulfotransferases and
          recombinant SULT1A1 and SULT1A3. Of the latter, SULT1A1 clearly shows the
          highest affinity for both iodothyronines and PAPS, but it remains to be
          established whether it is the prominent isoenzyme for sulfation of thyroid
          hormone in human liver and kidney.</description>
    </item> <item>
      <title>Sulfation of thyroid hormone by estrogen sulfotransferase (Article)</title>
      <link>http://repub.eur.nl/res/pub/9136/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>Sulfation is one of the pathways by which thyroid hormone is inactivated.
          Iodothyronine sulfate concentrations are very high in human fetal blood
          and amniotic fluid, suggesting important production of these conjugates in
          utero. Human estrogen sulfotransferase (SULT1E1) is expressed among other
          tissues in the uterus. Here we demonstrate for the first time that SULT1E1
          catalyzes the facile sulfation of the prohormone T4, the active hormone T3
          and the metabolites rT3 and 3,3'-diiodothyronine (3,3'-T2) with preference
          for rT3 approximately 3,3'-T2 &gt; T3 approximately T4. Thus, a single enzyme
          is capable of sulfating two such different hormones as the female sex
          hormone and thyroid hormone. The potential role of SULT1E1 in fetal
          thyroid hormone metabolism needs to be considered.</description>
    </item>
  </channel>
</rss>